Cargando…
C6-ceramide synergistically potentiates the anti-tumor effects of histone deacetylase inhibitors via AKT dephosphorylation and α-tubulin hyperacetylation both in vitro and in vivo
Histone deacetylase inhibitors (HDACIs) have shown promising anti-tumor effects for a variety of malignancies, however, many tumors are reportedly resistant to them. In this study, we made a novel discovery that co-administration of HDACIs (Trichostatin A (TSA) and others) and exogenous cell-permeab...
Autores principales: | Zhu, Q-y, Wang, Z, Ji, C, Cheng, L, Yang, Y-l, Ren, J, Jin, Y-h, Wang, Q-j, Gu, X-j, Bi, Z-g, Hu, G, Yang, Y |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3077291/ https://www.ncbi.nlm.nih.gov/pubmed/21368888 http://dx.doi.org/10.1038/cddis.2010.96 |
Ejemplares similares
-
Phenethyl isothiocyanate and paclitaxel synergistically enhanced apoptosis and alpha-tubulin hyperacetylation in breast cancer cells
por: Cang, Shundong, et al.
Publicado: (2014) -
Synthetic hyperacetylation of nucleosomal histones
por: Kajino, Hidetoshi, et al.
Publicado: (2020) -
Histone deacetylase 3 indirectly modulates tubulin acetylation
por: Bacon, Travis, et al.
Publicado: (2015) -
Histone hyperacetylation disrupts core gene regulatory architecture in rhabdomyosarcoma
por: Gryder, Berkley E., et al.
Publicado: (2019) -
Histone deacetylase (HDAC) 1 and 2 complexes regulate both histone acetylation and crotonylation in vivo
por: Kelly, R. D. W., et al.
Publicado: (2018)